tag rapid-launch 
pharmaphorum
AUGUST 21, 2022
The FDA has cleared Auvelity (dextromethorphan/bupropion) for the treatment of major depressive disorder (MDD) in adults, setting up a launch in the fourth quarter of this year.
pharmaphorum
JUNE 2, 2022
And of course, in many cases, these drugs have higher than average price tags compared to the wider market which is due to the limited – or in most cases – non-existent competition within a treatment area.”. Raising questions. While in the US, Congress has proposed limits to the Orphan Drug Tax Credit, as part of the Build Back Better Act.
pharmaphorum
MAY 24, 2021
Robb DeFilippis, managing director, life sciences, for end-to-end global creative production and sourcing partner Tag in the Americas agrees. As the leading creative production partner to brands and agencies, Tag offers a complementary skillset to in-house teams and advertising agencies to bring to life, extend and deploy creative ideas.
Expert insights. Personalized for you.
98 
Let's personalize your content